Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
248.43
+4.96 (2.04%)
At close: Feb 27, 2026, 4:00 PM EST
248.51
+0.08 (0.03%)
After-hours: Feb 27, 2026, 7:59 PM EST
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $598.69 billion as of February 27, 2026. Its market cap has increased by 59.27% in one year.
Market Cap
598.69B
Enterprise Value
627.92B
1-Year Change
59.27%
Ranking
Category
Stock Price
$248.43
Market Cap Chart
Since December 1, 1998, Johnson & Johnson's market cap has increased from $108.92B to $598.69B, an increase of 449.67%. That is a compound annual growth rate of 6.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 586.74B | 17.68% |
| Dec 31, 2025 | 498.60B | 43.20% |
| Dec 31, 2024 | 348.19B | -7.72% |
| Dec 29, 2023 | 377.32B | -18.30% |
| Dec 30, 2022 | 461.85B | 2.55% |
| Dec 31, 2021 | 450.36B | 8.70% |
| Dec 31, 2020 | 414.31B | 7.92% |
| Dec 31, 2019 | 383.91B | 10.92% |
| Dec 31, 2018 | 346.11B | -7.79% |
| Dec 29, 2017 | 375.36B | 19.76% |
| Dec 30, 2016 | 313.43B | 10.28% |
| Dec 31, 2015 | 284.22B | -2.90% |
| Dec 31, 2014 | 292.70B | 13.27% |
| Dec 31, 2013 | 258.42B | 33.02% |
| Dec 31, 2012 | 194.27B | 8.47% |
| Dec 30, 2011 | 179.09B | 5.44% |
| Dec 31, 2010 | 169.86B | -4.42% |
| Dec 31, 2009 | 177.71B | 7.05% |
| Dec 31, 2008 | 166.00B | -13.03% |
| Dec 31, 2007 | 190.88B | -0.28% |
| Dec 29, 2006 | 191.42B | 7.06% |
| Dec 30, 2005 | 178.79B | -5.00% |
| Dec 31, 2004 | 188.21B | 22.75% |
| Dec 31, 2003 | 153.33B | -3.90% |
| Dec 31, 2002 | 159.55B | -11.43% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 919.11B |
| AbbVie | 401.23B |
| Novartis AG | 320.51B |
| AstraZeneca | 319.52B |
| Merck & Co. | 302.77B |
| Amgen | 207.18B |
| Gilead Sciences | 182.53B |
| Novo Nordisk | 167.40B |